Drug Trial Radar · NCT07580716
Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
182
Planned (sponsor's estimate)
Start
May 1, 2026
Primary completion
Feb 2027
Study completion Apr 2028
Sponsor
- Lead sponsor
- Enlivex Therapeutics Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Nordic Bioscience Clinical Development
- First posted
- May 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled, Phase IIb study to evaluate intra-articular (IA) injections of Allocetra in participants with moderate-to-severe age related symptomatic primary knee osteoarthritis (OA).
Conditions
- Primary Knee Osteoarthritis
Interventions
AllocetraDrug
Allocetra is a cell-based therapy consisting of non-HLA-matched allogeneic peripheral blood mononuclear cells, induced to an apoptotic stable state.
PlaceboOther
The control used in this study will be placebo. Placebo solution containing all excipients except for the Allocetra cells.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Western Ontario and McMaster Universities Arthritis Index (WOMAC) Pain score at 3 monthsTime frame: 3 months.
- Western Ontario and McMaster Universities Arthritis Index (WOMAC) Function score at 3 monthsTime frame: 3 months.
- Primary Safety EndpointTime frame: Day 0 to 6 months.
Locations
17 sites in 3 countries. Site status is shown where the registry gives one.
Future Medical Research
Longwood, Florida · Recruiting
South Florida Research Phase I-IV
Miami, Florida · Recruiting
DelRicht Research @ Touro Medical Center
New Orleans, Louisiana · Recruiting
Oakland Medical Research
Troy, Michigan · Recruiting
Sanos Clinic Gandrup
Gandrup, Denmark · Recruiting
Sanos Clinic Herlev
Herlev, Denmark · Recruiting
Sanos Clinic Vejle
Vejle, Denmark · Recruiting
NZOZ Bif-Med. s.c
Bytom, Poland · Recruiting
Vita Longa Sp. z o.o.
Katowice, Poland · Recruiting
Centrum Medyczne PLEJADY
Krakow, Poland · Not yet recruiting
Medyczne Centrum Hetmańska
Poznan, Poland · Recruiting
Reumedika sp. z o.o.
Poznan, Poland · Recruiting
DC-MED Michal Kowalski S.K. Radom
Radom, Poland · Not yet recruiting
DC-MED Michal Kowalski S.K. Swidnica
Swidnica, Poland · Recruiting
Etg Justmed
Warsaw, Poland · Recruiting
Etg Warszawa
Warsaw, Poland · Recruiting
Migre Polskie Centrum
Wroclaw, Poland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.